In the human neuroblastoma SH-SY5Y cell line, the HDAC6 inhibitor was observed to induce an increase in the acetylation level of α-tubulin by inhibiting HDAC6 in a dose-dependent manner. Here, HDAC6 is linked to neuroblastoma.